Clinical trials
Phase 3 trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3,220 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 9 |
| 2001 | 18 |
| 2002 | 25 |
| 2003 | 53 |
| 2004 | 55 |
| 2005 | 63 |
| 2006 | 121 |
| 2007 | 107 |
| 2008 | 147 |
| 2009 | 163 |
| 2010 | 151 |
| 2011 | 148 |
| 2012 | 125 |
| 2013 | 107 |
| 2014 | 116 |
| 2015 | 112 |
| 2016 | 90 |
| 2017 | 135 |
| 2018 | 133 |
| 2019 | 117 |
| 2020 | 162 |
| 2021 | 190 |
| 2022 | 170 |
| 2023 | 168 |
| 2024 | 185 |
| 2025 | 183 |
| 2026 | 129 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,779 |
| Active, not recruiting | 444 |
| Recruiting | 401 |
| Terminated | 305 |
| Unknown status | 164 |
| Withdrawn | 64 |
| Not yet recruiting | 29 |
| Enrolling by invitation | 22 |
| Suspended | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 222 |
| AstraZeneca | 207 |
| Sanofi | 170 |
| Novartis Pharmaceuticals | 168 |
| Eli Lilly and Company | 137 |
| Bristol-Myers Squibb | 115 |
| Pfizer | 104 |
| Janssen Research & Development, LLC | 101 |
| Merck Sharp & Dohme LLC | 100 |
| GlaxoSmithKline | 76 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 160 |
| Diabetes Mellitus, Type 2 | 145 |
| Breast Neoplasms | 132 |
| COVID-19 | 69 |
| Diabetes Mellitus | 68 |
| Neoplasms | 68 |
| Neoplasm Metastasis | 63 |
| Arthritis, Rheumatoid | 54 |
| Asthma | 51 |
| Prostatic Neoplasms | 51 |
Trials
Showing 1 to 25 of 3,220. Each trial links to its page on Pharma Observatory.
3,120 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.